In Summary
Eli Lilly is in the 3rd week of a buy with the stop already moved to breakeven. Signal strength is moderate at 47 out of 100, and the stock ranks 121st among the 170 ongoing Long positions for US stocks: a case that calls for management, not reinforcement. The confirmation week closed bearish, signalling to keep the position unchanged.
Open BUY
·3rd week from start
·US stocks
·T1
IQS Phase
72
in tension
Signal Strength
47
medium · weak
Sizing
REDUCED
Ranking
#121 / 170
US stocks in progress
restricted Platinum content